Diagnostic pitfalls in Parkinson's disease: Case report

Arquivos de Neuro-Psiquiatria

Volumn 65, Issue 2 A, 2007, Pages 348-351

  Sekeff Sallem, Flávio Augusto ^a,b,c   Barbosa, Egberto Reis ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Pain; Parkinson's disease; Parkinsonism

Indexed keywords

AMANTADINE; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; BENSERAZIDE PLUS LEVODOPA; LIDOCAINE; PRAMIPEXOLE;

ACUPUNCTURE; ADD ON THERAPY; ADULT; AKINESIA; ARTICLE; BRAIN ANGIOGRAPHY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; DYSKINESIA; ELECTROENCEPHALOGRAM; ELECTROMYOGRAPHY; FEMALE; HUMAN; LEG PAIN; MEDICAL EXPERT; MEDICAL SPECIALIST; NEUROIMAGING; NEUROLOGIC EXAMINATION; ONSET AGE; PARESTHESIA; PARKINSON DISEASE; PATIENT REFERRAL; PSYCHOTHERAPY; RIGIDITY; SYMPTOM;

EID: 34347339597     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2007000200032     Document Type: Article

References (18)

1. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurology 2006;5:75-86.
2. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003;126:1271-1278.
3. Schrag A, Ben-Shlomo B, Brown R, Marsden CD, Quinn N. Young-onset Parkinson's disease revisited: clinical features, natural history, and mortality. Mov Disord 1998;13:885-894.
4. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-1292.
5. Lücking CB, Dürr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000;342:1560-1567.
6. Paviour DC, Surtees RAH, Lees AJ. Diagnostic considerations in juvenile parkinsonism. Mov Disord 2004;19:123-135.
7. Gilbert GJ. Biceps pain as the presenting symptom of Parkinson disease: effective treatment with l-dopa. South Med J 2004;97:776-777.
8. Buzas B, Max MB. Pain in Parkinson disease. Neurology 2004;62:2156-2157.
9. Djaldetti R, Shifrin A, Rogowski Z, et al. Quantitative measurements of pain sensation in patients with Parkinson disease. Neurology 2004;62:2171-2175.
10. Lewis SJG, Foltynie T, Blackwell AD, et al. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Nerurol Neurosurg Psychiatry 2005;76:343-348.
11. Ishikawa A, Miyatake T. A family with hereditary juvenile dystonia-parkinsonism. Mov Disord 1995;10:482-488.
12. Muthane UB, Swamy HS, Satishchandra P, et al. Early onset Parkinson's disease: are juvenile- and young-onset different? Mov Disord 1994;9:539-544.
13. Schelosky L, Poewe W. Topographical onset and progression of motor symptoms in idiopathic Parkinson's disease. Mov Disord 1990;5(Suppl 1):S13.
14. Dickson JM, Grünewald RA. Somatic symptom progression in idiopathic Parkinson's disease. Parkinsonism Relat Disord 2004;10:487-492.
15. Parent A. Carpenter's human neuroanatomy. 9.Ed. Philadelphia: Williams & Wilkins, 1996:557-582.
16. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
17. Vidailhet M, Bonnet AM, Marconi R, Gouider-Khouja N, Agid Y. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot? Neurology 1994;44:1613-1616.
18. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999;122:1437-1448.